In 1999, the U.S. Food and Drug Administration approved continuous glucose monitoring (CGM), a medical device that uses a ...

The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five ...

Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what’s next in the ...

Wearable technologies are starting to reshape how people manage health. Continuous glucose monitors that measure blood sugar ...

The market for modern health monitoring devices is rapidly developing worldwide. What is your vision of the current situation ...

Abbott Laboratories (ABT) has dropped by roughly 26% over the last five months, with the stock down 6% on Thursday alone.

The AI in remote patient monitoring market is booming, driven by chronic disease prevalence, aging populations, and digital ...

Key takeawaysWearable sensors that use microneedles to painlessly take samples at skin level could help personalize health ...

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

More and more patients are developing type 2 diabetes while still young. The diagnosis may lead to a life of disease.

At-home diagnostic testing is transforming urban India with convenient, preventive, and tech-driven healthcare solutions.

For long-term type 2 diabetes management, focus is shifting from blood sugar numbers to the scale. Learn why losing 15% of body weight may be the key to resetting your pancreas and achieving remission ...